Vktx stock buy or sell. 14% increase in the stock price over the next year.
Vktx stock buy or sell us Nov 12, 2025 · Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. It has also outperformed the broader Medical sector and the S&P 500 Index. 55%) stock collapsed on Tuesday, down 41. 5, after market close. VKTX’s Stock Price Performance & Valuation Mar 19, 2025 · Viking Therapeutics (VKTX 4. While media reports about rating changes by these brokerage-firm Sep 12, 2024 · The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Here’s what you need to know. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Let's take a look at what these Wall Street heavyweights have to say about Viking Therapeutics, Inc. Apr 17, 2025 · Combined with the recent bounce at the $19 ranges, we are cautiously upgrading the VKTX stock to a Buy. While media reports about rating changes by these brokerage-firm Real time Viking Therapeutics (VKTX) stock price quote, stock graph, news & analysis. Learn more about VKTX stock and its potential market leadership opportunities. The company was angling to enroll Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. (VKTX), which coincided with the stock’s unprecedented one-day drop of over 40% — from around $42 to the mid-$20s. Read more here. 6% against the industry’s 1. The company doesn't yet have any sales revenue, but Jul 2, 2025 · Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. We would like to show you a description here but the site won’t allow us. While results Oct 21, 2024 · Let us delve deeper to understand whether it would be a prudent move to buy, sell, or hold the stock at present. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts Apr 22, 2025 · When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. 14% increase in the stock price over the next year. Mar 13, 2025 · Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. (VKTX) currently has an average brokerage recommendation (ABR) of 1. Jan 30, 2025 · Let us delve deeper to understand whether it would be a prudent move to buy, sell, or hold the stock at present. (VKTX) before we discuss the 6 days ago · Viking Therapeutics, Inc. Aug 19, 2025 · Viking Therapeutics (VKTX 4. Stay ahead with Nasdaq. The stock has outperformed the sector and the S&P 500 during Nov 4, 2024 · Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. 39%) soared into the spotlight about a year ago when it delivered promising data on a drug candidate that aims to compete in an Viking Therapeutics (VKTX) shares crashed nearly 29% in today’s trade after the company’s much-anticipated weight-loss pill trial results raised fresh concerns among investors. Nov 18, 2024 · But that doesn't mean you should rush to buy the stock without understanding what else is going on with this stock and why it's making the changes it's making. The stock has outperformed the sector and the S&P 500 during Jan 20, 2025 · The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. Aug 21, 2025 · The stock has also underperformed the broader Medical sector and the S&P 500 during this timeframe, as shown in the chart below. VKTX Stock Underperforms Industry, Sector & S&P 500 The company is trading at a premium to the industry. Now here is why I’m buying VKTX instead of these power houses: VKTX oral data: Here’s why I’m loading up on short term calls; the readout for the Phase 1 Oral trial for VK2735 is due before the end of March. 5 days ago · It’s been three months since my initial analysis on Viking Therapeutics, Inc. Initially, this stock sold off from $95 due to NVO’s positive oral weight loss drug’s results. Since the company lacks a marketed drug in its portfolio, we do not expect it to Sep 9, 2025 · When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Read here for an investment analysis of VKTX stock. Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. VKTX’s Stock Price Performance & Valuation Year to date, the stock has surged 253. Feb 5, 2024 · Is VKTX Stock a Buy, Sell, or Hold? Viking's path, entering the tough GLP-1 and GIP agonist arena, especially with oral drugs, poses big hurdles. Mar 11, 2025 · Viking Therapeutics remains speculative despite progress in its clinical portfolio, notably the VK2735 program for obesity. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this Feb 5, 2025 · The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. Find market predictions, VKTX financials and market news. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this Aug 21, 2025 · The stock has also underperformed the broader Medical sector and the S&P 500 during this timeframe, as shown in the chart below. Read more about VKTX stock here. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this Oct 28, 2024 · Viking Therapeutics' VK2735 drug shows promising weight-loss results, driving a stock rally and positive analyst sentiment. While results showed up to 12. Find out why VKTX stock’s path remains uncertain, despite its strong pipeline performance. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy Viking Therapeutics (VKTX) has been analyzed by 14 analysts, with a consensus rating of Buy. Feb 24, 2025 · Given the optimism around its obesity candidate, we believe investors should stay invested in Viking Therapeutics, regardless of buyout speculations. stock symbol? Viking Therapeutics, Inc. Jul 21, 2025 · With no revenue expected, VKTX's Q2 report is likely to have the spotlight on pipeline moves across its obesity drugs. VKTX’s Stock Price Performance & Valuation Aug 19, 2025 · Viking Therapeutics (VKTX) shares crashed nearly 29% in todays trade after the companys much-anticipated weight-loss pill trial results raised fresh concerns among investors. Find the latest Viking Therapeutics, Inc. stock information by Barron's. (VKTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Jul 25, 2025 · Viking Therapeutics has strong R&D, dual-track obesity drugs, and solid cash runway. While media reports about rating changes by these brokerage-firm Shares of Viking Therapeutics VKTX plunged 36% in the past week after it reported mixed top-line results from a mid-stage study evaluating the safety and efficacy of the oral formulation of its Aug 21, 2025 · Viking Therapeutics stock sinks after mixed results from its obesity pill trial, raising doubts over safety, tolerability and future prospects. 5 days ago · How to buy Viking Therapeutics stock Since Viking Therapeutics is publicly traded, you can buy shares of the company like you would any other stock. Click here to read why VKTX is a Buy. Apr 22, 2025 · The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. While media reports about rating changes by these brokerage-firm 2 days ago · The 14 analysts that cover Viking Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $87. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this Jan 24, 2025 · Viking Therapeutics struggles with FDA approval and scaling up. Nov 15, 2025 · Ad Viking Therapeutics Stock: Buy or Sell?! New Viking Therapeutics Analysis from November 19 delivers the answer: The latest Viking Therapeutics figures speak for themselves: Urgent action needed for Viking Therapeutics investors. Jun 2, 2025 · Discover why Altimmune (ALT) and Viking Therapeutics (VKTX) are top picks for high-risk investors. ET after reporting what pharmaceutical analysts are calling "mixed results" for its new GLP-1 weight loss . It is usually referred to as NASDAQ:VKTX or VKTX-Q Oct 21, 2024 · Let us delve deeper to understand whether it would be a prudent move to buy, sell, or hold the stock at present. 55%) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may eventually rake in significant revenue from the anti-obesity market. 4 days ago · Should I buy Viking Therapeutics (VKTX)? Use the Zacks Rank and Style Scores to find out is VKTX is right for your portfolio. Oct 21, 2024 · Let us delve deeper to understand whether it would be a prudent move to buy, sell, or hold the stock at present. The stock has also outperformed the sector and the S&P 500. View real-time VKTX stock price and news, along with industry-best analysis. VKTX stock quote prices, financial information, real-time forecasts, and company news from CNN. View (VKTX) real-time stock price, chart, news, analysis, analyst reviews and more. Aug 21, 2025 · A bargain buy on the dip Commercial-stage biotechnology stocks tend to trade at mid-to-high single-digit multiples of sales. 42 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations Viking Therapeutics (VKTX) Stock forecast & analyst price target predictions based on 15 analysts offering 12-months price targets for VKTX in the last 3 months. Common Stock (VKTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts Oct 18, 2024 · Viking Stock Rises 29% in Three Months: Time to Buy, Hold or Sell? Sundeep Ganoria October 18, 2024 NVO Quick Quote NVO LLY Quick Quote LLY VKTX Quick Quote VKTX MDGL Quick Quote MDGL Better Aug 21, 2025 · Viking Therapeutics stock sinks after mixed results from its obesity pill trial, raising doubts over safety, tolerability and future prospects. Mar 26, 2024 · When it comes to rising stars in biotech, Viking Therapeutics (VKTX 0. 46%) there's more than one reason for why the stock is worth buying. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this Oct 18, 2024 · Shares of Viking Therapeutics VKTX have risen 29% in the past three months, significantly outperforming the industry’s 2. 4 days ago · Viking Therapeutics, Inc. See full list on stockinvest. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 19. is a American stock, trading under the symbol VKTX-Q on the NASDAQ (VKTX). VKTX’s Stock Price Performance & Valuation In the past year, the stock has risen over 40% against the industry’s 11% decline. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Oct 18, 2024 · Shares of Viking Therapeutics VKTX have risen 29% in the past three months, significantly outperforming the industry’s 2. 2% body weight reduction, investors were alarmed by a 28% discontinuation rate, much higher than placebo. The consensus among Wall Street research analysts is that investors should "moderate buy" VKTX shares. Here's what you need to know. Sep 12, 2024 · The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. (VKTX-Q) Frequently Asked Questions What is Viking Therapeutics, Inc. Media reports about these brokerage-firm-employed (or sell-side Jul 10, 2025 · Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. 3 days ago · There is currently 1 sell rating, 3 hold ratings, 9 buy ratings and 3 strong buy ratings for the stock. m. Nov 14, 2025 · The latest Viking Therapeutics stock prices, stock quotes, news, and VKTX history to help you invest and trade smarter. It is debatable whether this highly sought-after metric is effective because Wall Street Jan 30, 2025 · Let us delve deeper to understand whether it would be a prudent move to buy, sell, or hold the stock at present. May 27, 2025 · Buy Or Sell VKTX Stock? VKTX estimates (TIKR) As seen above, isn’t it clear that the company isn’t expected to generate substantial revenue through FY2028, with a more significant surge in FY2029. (VKTX) stock, including real-time price, chart, key statistics, news, and more. 5 days ago · Complete Viking Therapeutics Inc. 3 days ago · View Viking Therapeutics, Inc. Oct 21, 2024 · Devoid of marketed drugs, investors will likely focus on VKTX's pipeline updates when it reports third-quarter results. Click here to read an analysis of VKTX stock now. 5% growth. The sector is jam-packed. VKTX Stock Underperforms Industry, Sector & S&P 500 Image Source: Zacks Investment Research The company is trading at a premium to the industry. 07, which forecasts a 154. Oct 14, 2024 · The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. 03%) should probably be one of the first businesses to come to mind today. Jul 18, 2025 · According to the average brokerage recommendation (ABR), one should invest in Viking Therapeutics (VKTX). chart to track its stock's price action. Learn more on VKTX stock here. VKTX’s Stock Price Performance & Valuation Jan 30, 2025 · Viking Therapeutics VKTX is set to report fourth-quarter and full-year 2024 earnings on Feb. Aug 23, 2025 · Viking Therapeutics (VKTX) stock fell after Phase 2 trial results for obesity drug VK2735, drawing various views on its valuation on Wall Street. 7% decline. Discover real-time Viking Therapeutics, Inc. View live Viking Therapeutics, Inc. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this Apr 22, 2025 · When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Jul 21, 2025 · What Our Model Predicts for VKTX Stock Our proven model does not predict an earnings beat for Viking this time. Oct 25, 2024 · Viking Therapeutics shows significant clinical progress in obesity and NASH. Jan 3, 2025 · The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. 50% of analysts recommend a Strong Buy, 36% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell. Mar 11, 2025 · The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts Nov 8, 2024 · And while that proposition is certainly true with Viking Therapeutics, (VKTX 5. VKTX shares are currently trading below the 50 and 200-day moving averages. 4 days ago · Viking Therapeutics (VKTX) stock tumbled Wednesday after the biotech company said it over-enrolled one of its final-phase studies for weight-loss shot VK2735. 4% through 10:25 a. (VKTX) stock. While media reports about rating changes by these brokerage-firm Oct 31, 2025 · Complete Viking Therapeutics Inc. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? Dec 3, 2024 · After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now? Jan 20, 2025 · The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. Markets Viking Therapeutics (VKTX) Stock Rising on Positive Clinical Results Kaya Yurieff Feb 26, 2025 · Is Viking Therapeutics a Buy Right Now?Viking Therapeutics (VKTX +4. Media reports about these brokerage-firm-employed (or sell-side A high-level overview of Viking Therapeutics, Inc. Click here to read my most recent analysis of ALT and VKTX. 4 days ago · A detailed overview of Viking Therapeutics, Inc. Should I buy or sell VKTX stock? All Analysts Top Analysts Based on 7 analyst s offering ratings for Viking Therapeutics Inc. psisx muhk elrjr qvbbjnv sivp skxopj nqlghl rpvmh qnqql evie zicjj kvonj etsut fufvr tdndd